Conversely, CD138 ectodomain promotes in vivo tumor cell invasion as well as myeloma growth by facilitating the binding of very late antigen-4 to vascular endothelial growth factor receptor 2 (20, 47). The gene discussed is KDR; the disease is plasma cell myeloma.